Kamunting Street Capital Management, L.P. Pro Phase Labs, Inc. Transaction History

Kamunting Street Capital Management, L.P.

  • $98.1 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.13 - $7.89 $507,295 - $780,226
-98,888 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$4.89 - $7.82 $118,851 - $190,065
-24,305 Reduced 19.73%
98,888 $514,000
Q2 2021

Aug 16, 2021
BUY
$4.61 - $6.83 $117,094 - $173,482
25,400 Added 25.97%
123,193 $764,000
Q1 2021

May 17, 2021
BUY
$6.19 - $16.0 $605,338 - $1.56 Million
97,793 New
97,793 $723,000

Others Institutions Holding PRPH

# of Institutions
31
Shares Held
1.7M
Call Options Held
500
Put Options Held
6K
View Full List

About ProPhase Labs, Inc.

PRPH Quotes by TradingView
  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $38.5M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Kamunting Street Capital Management, L.P. Portfolio

Follow Kamunting Street Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email